Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022

SELL
$12.15 - $35.28 $1.01 Million - $2.93 Million
-83,000 Closed
0 $0
Q4 2021

Sep 21, 2023

BUY
$30.49 - $48.49 $2.53 Million - $4.02 Million
83,000 New
83,000 $2.83 Million
Q4 2021

Feb 14, 2022

BUY
$30.49 - $48.49 $2.53 Million - $4.02 Million
83,000 New
83,000 $2.83 Million
Q3 2019

Nov 13, 2019

SELL
$19.12 - $26.24 $174,546 - $239,544
-9,129 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$19.57 - $24.1 $81,606 - $100,497
4,170 Added 84.09%
9,129 $200,000
Q1 2019

May 15, 2019

BUY
$12.14 - $20.46 $41,919 - $70,648
3,453 Added 229.28%
4,959 $101,000
Q4 2018

Feb 14, 2019

BUY
$11.24 - $18.5 $16,927 - $27,861
1,506 New
1,506 $19,000
Q4 2017

Feb 14, 2018

SELL
$8.02 - $11.18 $91,307 - $127,284
-11,385 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$9.11 - $11.26 $103,717 - $128,195
11,385
11,385 $127,000

Others Institutions Holding NEO

About NEOGENOMICS INC


  • Ticker NEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 125,796,000
  • Market Cap $1.7B
  • Description
  • NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...
More about NEO
Track This Portfolio

Track Jefferies Group LLC Portfolio

Follow Jefferies Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.